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Background:  Oxidized low-density lipoprotein (OxLDL) and β2 glycoprotein I (β2GPI) have been identified in human atherosclerotic 
lesions and when complexed have been implicated as a pro-atherothrombotic antigen. We examined the association of OxLDL alone and 
OxLDL/β2GPI complex in patients with coronary artery disease (CAD) undergoing elective cardiac catheterization (ECC).
methods:  Serum was collected immediately prior to ECC in patients with suspected CAD who were either treated (n=385) or not treated 
(n=150) with statins. OxLDL and OxLDL/β2GPI complex levels were determined by ELISA. Disease severity was defined as none-minimal 
(<20%), moderate (20-75%), and severe >75% luminal diameter obstruction of any major coronary vessel.
results:  Both OxLDL and OxLDL/β2GPI complex were lower in patients on statins (p<0.001). In statin naïve patients, OxLDL/β2GPI 
complex, but not OxLDL alone, was associated with severe CAD (figure, p=0.036 by ANOVA). However, no association was observed in 
patients on statins. LDL4 and triglycerides increased with OxLDL/β2GPI complex quartiles (p=0.001 by ANOVA). OxLDL/β2GPI complex 
>0.26 mg/dl was predictive of severe atherosclerosis by ROC analysis in statin naïve patients (AUC=0.60, p=0.05).
Conclusion:  In statin naïve patients, OxLDL/β2GPI appears more predictive of CAD severity than OxLDL alone. Further prospective 
studies are required to explore the clinical utility of this novel biomarker. 
